| Date Checked | 2025-12-21 23:24:29 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | TRVI |
| AssetType | Common Stock |
| Name | Trevi Therapeutics Inc |
| Description | Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to the development of innovative therapies for serious neurology-mediated conditions. Its lead product candidate, Haduvio, targets significant unmet medical needs and is currently undergoing clinical trials, underscoring the company's commitment to advancing its robust therapeutic pipeline. With a strong focus on drug development and strategic commercialization opportunities, Trevi Therapeutics is poised to make a transformative impact in the neurology sector, offering promising solutions for patients suffering from debilitating conditions. |
| CIK | 1563880 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 195 CHURCH STREET, NEW HAVEN, CT, UNITED STATES, 06510 |
| OfficialSite | https://www.trevitherapeutics.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 1668274000 |
| EBITDA | -51200000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 1.48 |
| DividendPerShare | None |
| EPS | -0.37 |
| RevenuePerShareTTM | 0 |
| ProfitMargin | 0 |
| OperatingMarginTTM | 0 |
| ReturnOnAssetsTTM | -0.239 |
| ReturnOnEquityTTM | -0.369 |
| RevenueTTM | 0 |
| GrossProfitTTM | 0 |
| DilutedEPSTTM | -0.37 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 0 |
| AnalystTargetPrice | 21 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 8 |
| AnalystRatingHold | 0 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | - |
| PriceToBookRatio | 8.79 |
| EVToRevenue | - |
| EVToEBITDA | -4.915 |
| Beta | 0.834 |
| 52WeekHigh | 14.39 |
| 52WeekLow | 3.471 |
| 50DayMovingAverage | 11.58 |
| 200DayMovingAverage | 8.08 |
| SharesOutstanding | 128230000 |
| SharesFloat | 95230000 |
| PercentInsiders | 0.684 |
| PercentInstitutions | 102.979 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:24:29 |
| fresh | 1 |